Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease

This publication has 19 references indexed in Scilit:

• Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension
  The American Journal of Cardiology, 1994
• Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.
  Circulation, 1993
• Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension
  The Journal of Pediatrics, 1993
• Inhaled nitric oxide in congenital heart disease.
  Circulation, 1993
• Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
  The Lancet, 1992
• Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.
  Circulation, 1991
• Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
  Journal of Clinical Investigation, 1990
• Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.
  Journal of Clinical Investigation, 1989
• Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.
  Circulation, 1984
• The pulmonary vascular bed in patients with complete transposition of the great arteries.
  Circulation, 1976